- Home
- Standardized Extracts
- Belladonna Extract
Belladonna Extract (Atropa belladonna / Duboisia myoporoides) – Total Alkaloids 0.3–1.5%
Atropa belladonna / Duboisia myoporoides / Hyoscyamus niger
Pharmaceutical active / prescription-only in many markets
Orders are released after a compliance review of the intended use and destination market.
- Marker compound
- Total alkaloids
- Standardisation
- 0.3–1.5% (Titration)
- Assay method
- Titration
- Plant part
- Leaf
- Origin
- Australia, Egypt
Belladonna Extract (Atropa belladonna / Duboisia myoporoides) – Total Alkaloids 0.3–1.5%
Belladonna extract is produced from the leaf of Atropa belladonna / Duboisia myoporoides (Solanaceae family) and supplied as a standardized extract powder, standardized to Total alkaloids. Available grades: 0.3%, 1.5%. Typical sourcing: Australia, Egypt. For B2B formulation in pharmaceutical.
0.3%1.5%
Specifications
| Botanical name | Atropa belladonna / Duboisia myoporoides / Hyoscyamus niger |
| Common names | Belladonna, Duboisia, Henbane |
| Plant family / part | Solanaceae / Leaf |
| Marker compound | Total alkaloids |
| Phytochemical class | Alkaloids › Alkaloids (mixed) |
| Available grades | 0.3%, 1.5% |
| Assay method | Titration |
| Pharmacopoeia & standards | USP, Ph. Eur. (EP), British Pharmacopoeia |
| Form | Standardized Extract |
| Origin | Australia, Egypt |
| Pack sizes | Sample (50 g), 250 g, 1 Kg, 5 Kg, 25 Kg |
| Shelf life & storage | Typically 24 months in sealed original packaging; store cool, dry and away from light |
Regulatory status
- Pharmaceutical active / prescription-only in many markets
Supplied only to qualified business buyers for lawful manufacturing, research or pharmaceutical use. Buyers are responsible for compliance in their market.
Industries
Pharmaceutical
Documentation
The Technical Data Sheet and Safety Data Sheet (GHS format) can be downloaded from this page; the batch Certificate of Analysis is supplied on request. Confirm the assay method (HPLC, UV or gravimetric) on the CoA, as results differ between methods.
For B2B formulation and research use. Statements have not been evaluated by the FDA or other regulators; this ingredient is not intended to diagnose, treat, cure or prevent any disease.
Browse related
Same product form